ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 339579 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 339579; 2) Community: the network communities that were significantly associated with the response to NSC 339579; 3) Molecule: the relationships between components within communities and NSC 339579; 4) MDR: the compounds that were significantly associated with the NSC 339579.

NSC Compound Enrichment Correlation
NSC 734307 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide 0.00094423800811012 0.52068116
NSC 736680 6-(3-Aminopropyl)-5,6-dihydro-3-nitro-5,11-dioxo-9-thiomethy l-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.00094423800811012 0.56761965
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.00094423800811012 0.40712103
NSC 654509 Pirarubicin HCl 0.00103112124545269 0.36692571
NSC 666355 Null 0.00103112124545269 -0.31323691
NSC 692579 Null 0.00103112124545269 0.32683954
NSC 700455 Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- 0.00103112124545269 0.29144235
NSC 707904 Null 0.00103112124545269 0.65108766
NSC 740 Methotrexate 0.00103112124545269 0.81785414
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00103112124545271 0.49669857
Total:105  Current:6    [First] [Prev] [Next] [Last]